Abstract: The present invention pertains to methods for manufacturing high titer antibody products. In particular, the invention pertains, in part, to improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Additionally, the present invention further pertains to chromatographic procedures employed to successfully isolate the antibody product subject of the present disclosure.

Abstract: A method to evaluate respiratory health includes obtaining (i) one or more lung acoustic signals and (ii) one or more bioimpedance spectroscopy signals, wherein the one or more acoustic signals and the one or more bioimpedance spectroscopy signals are concurrently acquired over multiple respiratory cycles; generating values for (i) a first set of plurality of statistical features and/or a first set of time-frequency domain features using the obtained one or more lung acoustic signals and (ii) a second set of plurality of statistical features and/or a second set of time-frequency domain features using the obtained one or more bioimpedance spectroscopy signals; and generating, using one or more trained classifiers, a respiratory health value representative of a respiratory health of the patient by application of the values of the first and second sets of plurality of statistical features and time-frequency domain features to the one or more trained classifiers.

Abstract: The present invention pertains to methods for manufacturing high titer antibody products. In particular, the invention pertains, in part, to improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Additionally, the present invention further pertains to chromatographic procedures employed to successfully isolate the antibody product subject of the present disclosure.

Abstract: The present invention pertains to methods for manufacturing high titer antibody products. In particular, the invention pertains, in part, to improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Additionally, the present invention further pertains to chromatographic procedures employed to successfully isolate the antibody product subject of the present disclosure.

Abstract: The present invention pertains to methods for manufacturing high titer antibody products. In particular, the invention pertains, in part, to improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Additionally, the present invention further pertains to chromatographic procedures employed to successfully isolate the antibody product subject of the present disclosure.

Abstract: The present invention pertains to methods for manufacturing high titer antibody products. In particular, the invention pertains, in part, to improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Additionally, the present invention further pertains to chromatographic procedures employed to successfully isolate the antibody product subject of the present disclosure.

Abstract: The present invention pertains to methods for manufacturing high titer antibody products. In particular, the invention pertains, in part, to improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Additionally, the present invention further pertains to chromatographic procedures employed to successfully isolate the antibody product subject of the present disclosure.

Abstract: The disclosure provides biocompatible heat exchangers, artificial tissues, systems, and thermofluidic methods for spatiotemporal control of biological signaling and gene expression. The disclosure demonstrates that in heat exchangers containing embedded cells with heat-activatable transgenes, gene expression patterning can be tuned both spatially and dynamically by varying channel network architecture, fluid temperature, fluid flow direction, and stimulation timing in a user-defined manner and maintained in vivo.

Abstract: The present invention provides a polymerizable coating composition comprising: (i) 1-vinyl-2-pyrrolidinone (NVP) and 2-hydroxyethylmethacrylate (2-HEMA) for forming a copolymer; (ii) a poly(vinyl pyrrolidone) (PVP) polymer having a molecular weight of at least 500,000 g·mol?1; (iii) a co-polymerizable crosslinker for crosslinking the 1-vinyl-2-pyrrolidinone (NVP) and the 2-hydroxyethylmethacrylate (2-HEMA); (iv) a co-polymerizable initiator for initiating co-polymerisation of the 1-vinyl-2-pyrrolidinone (NVP) and 2-hydroxyethylmethacrylate (2-HEMA); (v) a surfactant selected from non-ionic triblock copolymers of ethylene oxide/propylene oxide, nonionic triblock copolymers of poly(propylene oxide) (PPO) and poly(ethylene oxide) (PEO), tetrablock copolymers of PPO and PEO; Triton X-100 and derivatives thereof, polyethylene glycols and derivatives thereof, PEO derivatives of sorbitan monolaurate, and combinations of any two or more thereof; (vi) a solvent, wherein a vinyl component is 1-vinyl-2-pyrrolidinone for

Abstract: A resilient pad for keyboards, such as computer keyboards, is disclosed. The pad is composed of EPDM blended with a copolymer of propylene oxide and allyl glycidyl ether. Each of the polymers is present in the amount of 10-90 parts. An accelerator system for the polymer blend is also disclosed. The pad has substantially improved resilience as measured by the hysteresis of the pad.

Abstract: A resilient pad for keyboards, such as computer keyboards, is disclosed. The pad is composed of EPDM blended with a copolymer of propylene oxide and allyl glycidyl ether. Each of the polymers is present in the amount of 10-90 parts. An accelerator system for the polymer blend is also disclosed. The pad has substantially improved resilience as measured by the hysteresis of the pad.